Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Surveys and Questionnaires 2Nicotine 2Narrow Band Imaging 2fluoromisonidazole 1X-Rays 1Varenicline 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Rubidium-82 1Referral and Consultation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Oral Hygiene 1Nutritional Status 1Nicotine Replacement Therapy 1Metoclopramide 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Interviews as Topic 1Immunohistochemistry 1Hearing 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Endoscopic Mucosal Resection 1Electroacupuncture 1Drug Delivery Systems 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hypopharyngeal Neoplasms × Hearing × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡